HLB Consortium announced today that it acquired PANAGENE, a company specializing in the development of materials for the treatment of genetic diseases and cancer diagnosis, to strengthen its cancer diagnosis business. 

Please refer to the following website for further details: HLB To Acquire PANAGENE To Strengthen Cancer Diagnosis Business Portfolio < Health < IT Wellness < 기사본문 - IT Times